Skip to main content
. 2015 Dec 28;2015:412068. doi: 10.1155/2015/412068

Table 1.

Clinical features of nine samples analyzed in this study.

Sample Clinical diagnosis Tissue-type obtained Age Major axis of tumor (cm) Preoperative therapy
NM1 Cervical cancer, stage Ib1 Normal myometrium 43 None
NM2 Cervical cancer, stage Ib2 Normal myometrium 38 None
NM3 Cervical cancer, stage Ib2 Normal myometrium 49 None
LM1 Interstitial myoma Leiomyoma 52 18 None
LM2 Submucosal myoma Leiomyoma 48 6 None
LM3 Submucosal myoma Leiomyoma 53 6 GnRHa
LMS1 Leiomyosarcoma, stage IV Leiomyosarcoma 49 25 None
LMS2 Leiomyosarcoma, stage I Leiomyosarcoma 54 20 None
LMS3 Leiomyosarcoma, stage I Leiomyosarcoma 83 10 None

GnRHa, gonadotrophin-releasing hormone analogues.